Corporate & Investor Presentation
Propeller has demonstrated compelling clinical outcomes
1) Impact of the Propeller solution tracking inhaler usage and location
SABA use over time
# per day
Symptom free days
%
Healthcare utilization
Events
2.0
1.5
-50%
1.0
0.5
Uncontrolled
COPD
0.0
0
Uncontrolled
Asthma
75
50
50
25
+32%
0
50
100
150
200
0
50
100
150
200
Drives a decrease in
medication
Adherence
%
36
+58%
57
40
Control
Intervention
Drives an
improvement in
adherence
50 2022 ResMed | Corporate & Investor Presentation - updated 27JAN22
Drives an improvement in
QOL
QoL: Rescue Inhaler use per day
# times used
1.5
1.0
-75%
0.5
0.0
1
180
Drives an
improvement in
QOL
-25%
79
Before
59
After
Drives a reduction in
healthcare utilization
Acute care utilization
Events per 100 patient years
13
Pre-enrollment
Post-enrollment
12
6
5
365
ED + Hosp.
ED
2
0
Hosp.
Drives a reduction in
healthcare utilization
ResMedView entire presentation